Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence?

Breast

Volumn 20, Issue 4, 2011, Pages 351-357

  Lohsiriwat, Visnu ^a,b   Curigliano, Giuseppe ^a   Rietjens, Mario ^a   Goldhirsch, Aron ^a   Petit, Jean Yves ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adipocyte; Adipokines; Breast cancer; Breast reconstruction; Lipofilling; Plastic surgery

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 11; LEPTIN; STROMELYSIN 3; TUMOR NECROSIS FACTOR;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; AUTOLOGOUS FAT TRANSPLANTATION; AUTOTRANSPLANTATION; BREAST CALCIFICATION; BREAST CANCER; BREAST CARCINOGENESIS; BREAST RECONSTRUCTION; CANCER RECURRENCE; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; FAT NECROSIS; HUMAN; LIPID TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 79960567239     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.01.003     Document Type: Article

References (83)

1. Bredart A., Petit J.Y. Partial mastectomy: a balance between oncology and aesthetics?. Lancet Oncol 2005, 6(3):130.
2. Cordeiro P.G. Breast reconstruction after surgery for breast cancer. N Engl J Med 2008, 359(15):1590-1601.
3. Petit J.Y., Rietjens M., Garusi C. Breast reconstructive techniques in cancer patients: which ones, when to apply, which immediate and long term risks?. Crit Rev Oncol Hemat 2001, 38(3):231-239.
4. Petit J.Y., De Lorenzi F., Rietjens M., Intra M., Martella S., Garusi C., et al. Technical tricks to improve the cosmetic results of breast-conserving treatment. Breast 2007, 16(1):13-16.
5. Rietjens M., Urban C.A., Rey P.C., Mazzarol G., Maisonneuve P., Garusi C., et al. Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast 2007, 16(4):387-395.
6. Amar O., Bruant-Rodier C., Lehmann S., Bollecker V., Wilk A. Fat tissue transplant: restoration of the mammary volume after conservative treatment of breast cancers, clinical and radiological considerations. Ann Chir Plast Esth 2008, 53(2):169-177.
7. Delay E., Gosset J., Toussoun G., Delaporte T., Delbaere M. Efficacy of lipomodelling for the management of sequelae of breast cancer conservative treatment. Ann Chir Plast Esth 2008, 53(2):153-168.
8. Kijima Y., Yoshinaka H., Owaki T., Aikou T. Early experience of immediate reconstruction using autologous free dermal fat graft after breast conservational surgery. J Plast Reconstr Aes Surg 2007, 60(5):495-502.
9. Missana M.C., Laurent I., Barreau L., Balleyguier C. Autologous fat transfer in reconstructive breast surgery: indications, technique and results. Eur J Surg Oncol 2007, 33(6):685-690.
10. Rigotti G., Marchi A., Galie M., Baroni G., Benati D., Krampera M., et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg 2007, 119(5):1409-1422.
11. Coleman S.R., Saboeiro A.P. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 2007, 119(3):775-785.
12. Spear S.L., Newman M.K. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg 2007, 119(3):786-787.
13. Bircoll M. Cosmetic breast augmentation utilizing autologous fat and liposuction techniques. Plast Reconstr Surg 1987, 79(2):267-271.
14. Coleman S.R. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg 2006, 118(3):108S-120S.
15. Spear S.L., Wilson H.B., Lockwood M.D. Fat injection to correct contour deformities in the reconstructed breast. Plast Reconstr Surg 2005, 116(5):1300-1305.
16. Hang-Fu L., Marmolya G., Feiglin D.H. Liposuction fat-fillant implant for breast augmentation and reconstruction. Aesthet Plast Surg 1995, 19(5):427-437.
17. Yoshimura K., Sato K., Aoi N., Kurita M., Hirohi T., Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthet Plast Surg 2008, 32(1):48-55.
18. Patrick C.W. Adipose tissue engineering: the future of breast and soft tissue reconstruction following tumor resection. Semin Surg Oncol 2000, 19(3):302-311.
19. Mojallal A., Foyatier J.L. [Historical review of the use of adipose tissue transfer in plastic and reconstructive surgery]. Ann Chir Plast Esthet 2004, 49(5):419-425.
20. Coleman S.R. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg 1995, 19(5):421-425.
21. Coleman S.R. Structural fat grafts: the ideal filler?. Clin Plast Surg 2001, 28(1):111-119.
22. Coleman S.R. Facial recontouring with lipostructure. Clin Plast Surg 1997, 24(2):347-367.
23. Illouz Y.G., Sterodimas A. Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg 2009 Jun 4, [Epub ahead of print].
24. Gutowski K.A., Baker S.B., Coleman S.R., Khoobehi K., Lorenz H.P., Massey M.F., et al. Current applications and safety of autologous fat grafts: a report of the ASPS Fat Graft Task Force. Plast Reconstr Surg 2009 Mar 23, [Epub ahead of print].
25. Pierrefeu-Lagrange A.C., Delay E., Guerin N., Chekaroua K., Delaporte T. [Radiological evaluation of breasts reconstructed with lipomodeling]. Ann Chir Plast Esthet 2006, 51(1):18-28.
26. Pulagam S.R., Poulton T., Mamounas E.P. Long-term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature. Breast J 2006, 12(1):63-65.
27. Kwak J.Y., Lee S.H., Park H.L., Kim J.Y., Kim S.E., Kim E.K. Sonographic findings in complications of cosmetic breast augmentation with autologous fat obtained by liposuction. J Clin Ultrasound 2004, 32(6):299-301.
28. Vona-Davis L., Rose D.P. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007 Jun, 14(2):189-206.
29. Hou W.K., Xu Y.X., Yu T., Zhang L., Zhang W.W., Fu C.L., et al. Adipocytokines and breast cancer risk. Chin Med J 2007, 120(18):1592-1596.
30. Lamszus K., Jin L., Fuchs A., Shi E., Chowdhury S., Yao Y., et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 1997, 76(3):339-353.
31. Markey A.C., Glogau R.G. Autologous fat grafting: comparison of techniques. Dermatol Surg 2000, 26(12):1135-1139.
32. Pu L.L.Q., Coleman S.R., Cui X., Ferguson R.E.H., Vasconez H.C. Autologous fat grafts harvested and refined by the Coleman technique: a comparative study. Plast Reconstr Surg 2008, 122(3):932-937.
33. Rieck B., Schlaak S. Measurement in vivo of the survival rate in autologous adipocyte transplantation. Plast Reconstr Surg 2003, 111(7):2315-2323.
34. Shiffman M.A., Mirrafati S. Fat transfer techniques: the effect of harvest and transfer methods on adipocyte viability and review of the literature. Dermatol Surg 2001, 27(9):819-826.
35. Toledo L.S., Mauad R. Fat injection: a 20-year revision. Clin Plast Surg 2006, 33(1):47-53.
36. Katz A.J., Llull R., Hedrick M.H., Futrell J.W. Emerging approaches to the tissue engineering of fat. Clin Plast Surg 1999, 26(4):587-603.
37. Lin S.D., Wang K.H., Kao A.P. Engineered adipose tissue of predefined shape and dimensions from human adipose-derived mesenchymal stem cells. Tissue Eng Part A 2008, 14(5):571-581.
38. Moseley T.A., Zhu M., Hedrick M.H. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006, 118(3):121S-128S.
39. Patrick C.W. Breast tissue engineering. Annu Rev Biomed Eng 2004, 6:109-130.
40. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrin Met 2000, 11(8):327-332.
41. Bradley R.L., Cleveland K.A., Cheatham B. The adipocyte as a secretory organ: mechanisms of vesicle transport and secretory pathways. Recent Prog Horm Res 2001, 56:329-358.
42. Kim S., Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte. J Nutr 2000, 130(12):3110S-3115S.
43. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes 1998, 22(12):1145-1158.
44. Trujillo M.E., Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr Rev 2006, 27(7):762-778.
45. Imagawa W., Pedchenko V.K., Helber J., Zhang H.Z. Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002, 80(2):213-230.
46. Iyengar P., Combs T.P., Shah S.J., Gouon-Evans V., Pollard J.W., Albanese C., et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003, 22(41):6408-6423.
47. Kilroy G.E., Foster S.J., Wu X., Ruiz J., Sherwood S., Heifetz A., et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007, 212(3):702-709.
48. Manabe Y., Toda S., Miyazaki K., Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003, 201(2):221-228.
49. Schaffler A., Scholmerich J., Buechler C. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endoc 2007, 3(4):345-354.
50. Iyengar P., Espina V., Williams T.W., Lin Y., Berry D., Jelicks L.A., et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005, 115(5):1163-1176.
51. Koerner A., Kratzsch J., Kiess W. Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005, 19(4):525-546.
52. Motrescu E.R., Blaise S., Etique N., Messaddeq N., Chenard M.P., Stoll I., et al. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 2008, 27(49):6347-6355.
53. Motrescu E.R., Rio M.C. Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle. Biol Chem 2008, 389(8):1037-1041.
54. Perera C.N., Spalding H.S., Mohammed S.I., Camarillo I.G. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach. Exp Biol Med 2008, 233(6):708-720.
55. Rahimi N., Saulnier R., Nakamura T., Park M., Elliott B. Role of hepatocyte growth-factor in breast-cancer - A novel mitogenic factor secreted by adipocytes. DNA Cell Biol 1994, 13(12):1189-1197.
56. Rahimi N., Tremblay E., McAdam L., Roberts A., Elliott B. Autocrine secretion of TGF-beta 1 and TGF-beta 2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells. In Vitro Cell Dev Biol Anim 1998, 34(5):412-420.
57. Elliott B.E., Tam S.P., Dexter D., Chen Z.Q. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J Cancer 1992, 51:416-424.
58. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002, 296:1046-1049.
59. Celis J.E., Moreira J.M.A., Cabezon T., Gromov P., Friis E. Rank F et.al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 2005, 4(4):492-522.
60. Mantzoros C., Petridou E., Dessypris N., Chavelas C., Dalamaga M., Alexe D.M., et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004, 89(3):1102-1107.
61. Körner A., Pazaitou-Panayiotou K., Kelesidis T., Kelesidis I., Williams C.J., Kaprara A., et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 2007, 92(3):1041-1048.
62. Tworoger S.S., Eliassen A.H., Kelesidis T., Colditz G.A., Willett W.C., Mantzoros C.S., et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007, 92(4):1510-1516.
63. Kang J.H., Lee Y.Y., Yu B.Y., Yang B.S., Cho K.H., Yoon D.K., et al. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005, 28(11):1263-1269.
64. Barb D., Williams C.J., Neuwirth A.K., Mantzoros C.S. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 2007, 86(3):s858-66.
65. Nakayama S., Miyoshi Y., Ishihara H., Noguchi S. Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat 2008, 112(3):405-410.
66. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 2000, 14(14):2329-2338.
67. Miyoshi Y., Funahashi T., Tanaka S., Taguchi T., Tamaki Y., Shimomura I., et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006, 118(6):1414-1419.
68. Garofalo C., Surmacz E. Leptin and cancer. J Cell Physiol 2006, 207:12-22.
69. Mantzoros C.S., Bolhke K., Moschos S., Cramer D.W. Leptin in relation to carcinoma in situ of the breast: a study of premenopausal cases and controls. Int J Cancer 1999, 80(4):523-526.
70. Wu M.H., Chou Y.C., Chou W.Y., Hsu G.C., Chu C.H., Yu C.P., et al. Circulating levels of leptin, adiposity and breast cancer risk. Brit J Cancer 2009 Feb, 100(4):578-582.
71. Nkhata K.J., Ray A., Schuster T.F., Grossmann M.E., Cleary M.P. Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep 2009 Jun, 21(6):1611-1619.
72. Andarawewa K.L., Motrescu E.R., Chenard M.P., Gansmuller A., Stoll I., Tomasetto C., et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 2005, 65(23):10862-10871.
73. Meng L., Zhou J., Sasano H., Suzuki T., Zeitoun K.M., Bulun S.E. Tumor necrosis factor α and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein α and peroxisome proliferator-activated receptor γ: mechanism of desmoplastic reaction. Cancer Res 2001, 61(5):2250-2255.
74. Van Valckenborgh D., De Wever O., Hendrix A., Bracke M., Vandenbroecke R., Van Belle S., et al. Role of adipocyte-derived resistin in breast cancer. Breast Cancer Res Treat 2006, 100. S299-S.
75. Piasecki J.H., Gutowski K.A., Lahvis G.P., Moreno K.I. An experimental model for improving fat graft viability and purity. Plast Reconstr Surg 2007, 119(5):1571-1583.
76. Shoshani O., Livne E., Annoni M., Shupak A., Berger J., Ramon Y., et al. The effect of interleukin-8 on the viability of injected adipose tissue in nude mice. Plast Reconstr Surg 2005, 115(3):853-859.
77. Vashi A.V., Abberton K.M., Thomas G.P., Morrison W.A., O'Connor A.J., Cooper-White J.J., et al. Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng 2006, 12(11):3035-3043.
78. Yi C.G., Pan Y., Zhen Y., Zhang L.X., Zhang X.D., Shu M.G., et al. Enhancement of viability of fat grafts in nude mice by endothelial progenitor cells. Dermatol Surg 2006, 32(12):1437-1443.
79. Howard M.A., Polo K., Pusic A.L., Cordeiro P.G., Hidalgo D.A., Mehrara B., et al. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg 2006, 117(5):1381-1386.
80. Rietjens M., De Lorenzi F., Rossetto F., Brenelli F., Manconi A., Martella S., et al. Safety of fat grafting in secondary breast reconstruction after cancer. J Plast Reconstr Aesthet Surg 2010 Aug 5, [Epub ahead of print].
81. Rigotti G., Marchi A., Stringhini P., Baroni G., Galiè M., Molino A.M., et al. Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction. Aesth Plast Surg 2010, 34:475.
82. Chan C.W., McCulley S.J., Macmillan R.D. Autologous fat transfer-a review of the literature with a focus on breast cancer surgery. J Plast Reconstr Aesthet Surg 2008, 61(12):1438-1448.
83. Perrot P., Rousseau J., Bouffaut A.L., Rédini F., Cassagnau E., Deschaseaux F., et al. Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence. PLoS One 2010 Jun 8, 5(6):e10999.